Month: September 2020

MONTREAL, Sept. 09, 2020 (GLOBE NEWSWIRE) — MPV Exploration Inc. (“MPV” or the “Company“) (CSE : MPV) is pleased to provide an update with respect to its proposed business combination (the “Transaction”) with Entheon Biomedical Corp. (“Entheon“), in connection with which the Company will (i) consolidate its issued and outstanding common shares (the “Consolidation“) on the basis of one post-Consolidation common share (each, a  “Share“) for every three (3) pre-Consolidation common shares of the Company; (ii) acquire all of the issued and outstanding shares of Entheon pursuant to a three-cornered amalgamation (the “Amalgamation”) between Entheon and a wholly-owned subsidiary of the Company (“Subco”) as a result of which each of the shareholders of Entheon (the “Entheon Shareholders”)...

MONTRÉAL, 09 sept. 2020 (GLOBE NEWSWIRE) — Exploration MPV Inc. (« MPV » ou la « Société ») (CSE : MPV) a le plaisir de faire une mise à jour en relation avec le regroupement d’entreprises proposé (la « Transaction ») avec Entheon Biomedical Corp. (« Entheon »), au terme de laquelle la Société : (i) procédera à la consolidation de toutes les actions ordinaires émises et en circulation (la « Consolidation ») sur la base d’une action ordinaire postérieure (chacune, une « Action ») pour chaque trois (3) actions ordinaires en circulation du capital de la Société; (ii) va acquérir toutes les actions émises et en circulation d’Entheon dans le cadre d’une fusion tripartite (la « Fusion ») entre Entheon et une filiale en propriété exclusive de la Société (« Subco »), à la suite de laquelle chacun des actionnaires d’Entheon...

Hluthafafundur Regins hf. var haldinn klukkan 16:00, miðvikudaginn 9. september 2020  í Hörpu, tónlistar- og ráðstefnuhúsi, í Rímu fundarsal, Austurbakka 2, 101 Reykjavík. Niðurstöður fundarins voru eftirfarandi:1.    Heimild til handa stjórn til hækkunar hlutafjár:Hluthafafundur Regins samþykkti breytingu á 4. gr. samþykkta félagsins þess efnis að við greinina bætist heimild til handa stjórn félagsins til að auka hlutafé þess um allt að kr. 40.000.000 að nafnverði. Hluthafar skulu hafa forgangsrétt að öllum nýjum hlutum í hlutfalli við skráða hlutafjáreign sína. Heimildin skal falla niður þann 10. mars 2021.Önnur mál:Engin önnur mál voru tekin til afgreiðslu á fundinum.ViðhengiReginn hf. – Hluthafafundur – kynning – 09092020

AUSTIN, Texas, Sept. 09, 2020 (GLOBE NEWSWIRE) — Superconductor Technologies Inc. (STI) (Nasdaq: SCON) will effect a one-for-ten (1:10) reverse split of its common stock on September 10, 2020. The reverse stock split, which was authorized by its Board of Directors, was approved by STI’s stockholders on September 9, 2020. Upon market open Thursday, September 10, 2020, STI’s common stock will continue trading under the symbol SCON on a split-adjusted basis with a new CUSIP number: 867931 701.STI has implemented the reverse stock split for the purpose of regaining compliance with the Nasdaq Stock Market’s listing maintenance standard that requires STI to maintain at least a $1.00 per share minimum bid price. The reverse stock split will reduce the number of outstanding shares of STI common stock from approximately...

Saint Herblain (France), September 9, 2020 – Valneva SE (“Valneva”), a specialty vaccine company, today announced the signing of a new contract, lasting up to three years, with the U.S. government Department of Defense (DoD) for the supply of its Japanese encephalitis (JE) vaccine IXIARO®.The new contract spans a total of three years (one base year, plus two option years) with a base-year value of $61 million. The DoD has the option to purchase a total of $76 million – $105 million worth of IXIARO® across the two option years.  Deliveries for the base-year will commence in the fourth quarter 2020.Franck Grimaud, Chief Business Officer of Valneva commented, “We are very pleased with this new contract including the longer duration of up to three years – a clear demonstration of the clinical need for personnel deployed to JE endemic...

Saint Herblain (France), 9 septembre 2020 – Valneva SE (“Valneva”), société spécialisée dans les vaccins contre des maladies générant d’importants besoins médicaux, a annoncé aujourd’hui la signature d’un nouveau contrat d’une durée maximale de trois ans avec le Département américain de la Défense pour la fourniture de son vaccin contre l’encéphalite japonaise IXIARO®.Ce nouveau contrat porte sur une période de trois ans (une première année ferme et deux années supplémentaires via des options) pour une valeur de $61 millions la première année. Le Département américain de la Défense a ensuite la possibilité d’acheter le vaccin pour une valeur de $76 millions à $105 millions sur deux ans. Les livraisons du vaccin pour la première année vont débuter au quatrième trimestre 2020.Franck Grimaud, Chief Business Officer de Valneva a indiqué,...

Westport, CT, Sept. 09, 2020 (GLOBE NEWSWIRE) —Randomized, Double-Blind, Placebo-Controlled, Clinical Trial of Merimepodib in Combination with Remdesivir in Hospitalized Adults with COVID-19 Who Require Non-Invasive Ventilation/High Flow Oxygen Devices or Supplemental OxygenBioSig Technologies, Inc.’s (Nasdaq: BSGM) (“BioSig” or the “Company”) subsidiary, ViralClear Pharmaceuticals, Inc. (ViralClear), today announced that it will host a conference call to discuss its Phase 2 clinical trial.  The study is a randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of merimepodib (MMPD) in combination with remdesivir for hospitalized adult patients who have confirmed infection with SARS-CoV-2 and require non-invasive ventilation/high flow oxygen devices or supplemental oxygen (score of 3 or 4, respectively,...

VANCOUVER, British Columbia, Sept. 09, 2020 (GLOBE NEWSWIRE) — enCore Energy Corp. (TSXV:EU; OTCQB:ENCUF) (the “Company”) is pleased to announce that effective September 1, 2020 it has entered into a binding letter of intent (“Agreement”) with Westwater Resources Inc.  (Nasdaq: WWR) (“Westwater”) to acquire all of Westwater’s United States uranium assets.  These assets include two two licensed Texas-based uranium production facilities, mineral exploration leases in Texas, and more than 270 square miles (180,000 acres) of patented mineral rights in New Mexico with four projects containing significant historical mineral estimates. This acquisition will more than double the Company’s current mineral rights and holdings with historical mineral estimates, and add two already licensed uranium production facilities. William M. Sheriff,...

 Voisins-Le-Bretonneux, 9 September 2020 at 18HMatthew (Matt) GIBSON (52): International Business Development Director Orege.Matt brings to Orege 30 years of management and business development experience in the water industry in over 60 countries throughout Europe, The Americas, Asia and the Middle East, including a wealth of experience in the USA and the UK. He is based in the UK.Starting out in technical roles at Ashbrook Simon-Hartley, a pioneer and worldwide leader in belt filter presses and other sludge treatment equipment, Matt progressed through engineering, sales and senior management roles to become CEO of that business.  Following Alfa Laval’s acquisition of Ashbrook Simon-Hartley some 7 years ago, Matt was appointed Global Business Development Manager. During his time at Ashbrook Simon-Hartley and Alfa Laval Matt achieved...

  Voisins-Le-Bretonneux, le mercredi 9 septembre 2020 à 18H Matthew (Matt) GIBSON (52 ans): Directeur du Développement Commercial International d’Orège.Matt fera bénéficier Orège de ses 30 années d’expérience en management et « Business Development » dans l’industrie de l’eau et dans plus de 60 pays (Europe, Continent Américain, Asie, Moyen Orient). Il est basé au Royaume-Uni.Après avoir occupé des postes techniques chez Ashbrook Simon-Hartley, alors pionnier et leader mondial des filtres à bandes et autres équipements de traitement des boues, Matt a mené sa carrière en évoluant dans diverses fonctions de l’ingénierie et du « Business Development » avant de devenir le CEO de cette entreprise.Il y a 7 ans lors de l’acquisition d’Ashbrook Simon-Hartley par Alfa Laval, Matt fut nommé « Global International Business Development Manager »...